J&J Sets Erleada On Real-Time Pathway For Castration-Sensitive Prostate Cancer Claim
Erleada is ninth product known to be using US FDA’s Real-Time Oncology Review pilot program, as shown in our comprehensive chart.
Erleada is ninth product known to be using US FDA’s Real-Time Oncology Review pilot program, as shown in our comprehensive chart.